FDA Inspection 1177254 — Gojo Industries

Gojo Industries — FEI 3011493299

The FDA completed an inspection of Gojo Industries on August 5, 2022 in Wooster, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 5, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wooster, OH (United States)

Citations

IDCFRDescription
180921 CFR 211.160(a)Following/documenting laboratory controls
360321 CFR 211.160(b)Scientifically sound laboratory controls
441321 CFR 211.194(a)(8)Second person sign off